Remove BioTech Remove Health Policy Remove Patient Experience Remove Study
article thumbnail

Will Technology Cure Americans’ Health Care System Ills? Considering Google and Ascension Health’s Data Deal

Health Populi

Note that hospitals garnered only about one-half of people in this study, and pharma and health plans fell to one-third of Americans’ responses to the question. health care. Was this due to the growing experience and reporting of surprise medical bills?

BioTech 160
article thumbnail

In U.S. Health Care, It’s Still the Prices, Stupid – But Transparency and Consumer Behavior Aren’t Working As Planned

Health Populi

As the Harvard Chan-POLITICO study points out, prescription drug costs are top-of-mind for health consumers in America. First, a Wall Street Journal profile of Bluebird Bio , a biotech firm that plans to sell gene-replacement therapy extending annual payments to patients based on whether the drug is effective.

BioTech 160
article thumbnail

A Matter of Trust, Perception, Risk, and Uncertainty – The Big Issues Raised by the Acquisition of PatientsLikeMe and Other Patient Data Transactions

Health Populi

For more color, read Jane’s April 2008 report, “The Wisdom of Patients,” where she wrote about PLM in its start-up phase (see section on page 20 entitled “ An Ongoing, Live Outcomes Study ”). When this occurred, it didn’t cause more than a ripple of interest outside biotech. But the U.S. citizens’ personal data.